These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Paralysis after long-term administration of vecuronium. Anesthesiology; 1990 Aug; 73(2):364-6. PubMed ID: 1974397 [No Abstract] [Full Text] [Related]
27. [Paralysis after long-term administration of neuromuscular blocking agents]. Sugai N Masui; 1992 Jan; 41(1):2-10. PubMed ID: 1545497 [TBL] [Abstract][Full Text] [Related]
28. Vecuronium infusions for prolonged muscle relaxation in the intensive care unit. Darrah WC; Johnston JR; Mirakhur RK Crit Care Med; 1989 Dec; 17(12):1297-300. PubMed ID: 2574099 [TBL] [Abstract][Full Text] [Related]
29. Dose requirements of vecuronium, pancuronium, and atracurium during orthotopic liver transplantation. O'Kelly B; Jayais P; Veroli P; Lhuissier C; Ecoffey C Anesth Analg; 1991 Dec; 73(6):794-8. PubMed ID: 1683184 [TBL] [Abstract][Full Text] [Related]
30. Persistent paralysis after vecuronium administration. Conway EE N Engl J Med; 1992 Dec; 327(26):1882. PubMed ID: 1360147 [No Abstract] [Full Text] [Related]
31. Neurologic recovery and functional improvement after vecuronium-induced quadriparesis. Munin MC; Balu GR; Giuliani MJ; Hegde SK Am J Phys Med Rehabil; 1995; 74(5):375-9. PubMed ID: 7576415 [TBL] [Abstract][Full Text] [Related]
32. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit. Frankel H; Jeng J; Tilly E; St Andre A; Champion H Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538 [TBL] [Abstract][Full Text] [Related]
33. Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients. Buck ML; Reed MD Clin Pharm; 1991 Jan; 10(1):32-48. PubMed ID: 1825627 [TBL] [Abstract][Full Text] [Related]
34. Simulating the time-course of clinical paralysis. Shanks CA Int J Clin Monit Comput; 1988; 5(4):201-5. PubMed ID: 2907346 [TBL] [Abstract][Full Text] [Related]
35. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Danon MJ; Carpenter S Muscle Nerve; 1991 Nov; 14(11):1131-9. PubMed ID: 1684024 [TBL] [Abstract][Full Text] [Related]
37. Vecuronium induced prolonged paralysis in two pediatric intensive care patients. Kendirli T; Incesoy S; Ince E; Tutar E Can J Neurol Sci; 2005 Feb; 32(1):130-1. PubMed ID: 15825561 [No Abstract] [Full Text] [Related]
38. Electrophysiological features of vecuronium induced prolonged neuromuscular blockade. Aggarwal A; Gutmann L; Gutierrez A Muscle Nerve; 1994 Feb; 17(2):251-2. PubMed ID: 7906862 [No Abstract] [Full Text] [Related]
39. Early recognition of risk factors for persistent effects of vecuronium. Sanders KA; Aucker R South Med J; 1996 Apr; 89(4):411-4. PubMed ID: 8614883 [TBL] [Abstract][Full Text] [Related]
40. The use of neuromuscular blockers to facilitate mechanical ventilation in severe asthma. Jones C; Mulleague L; Jankowski S Br J Hosp Med (Lond); 2009 Jan; 70(1):57. PubMed ID: 19357585 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]